Rachel Goode

Rachel Goode is an accomplished legal professional specializing in intellectual property within the biopharmaceutical sector. Currently serving as Senior Vice President and Head of Legal and Intellectual Property for Biopharmaceuticals at Fresenius Kabi since January 2018, Rachel has also held various leadership roles in the company, including Vice President positions for both Biosimilars and Intellectual Property. Prior experience includes Senior Director Patent Attorney at Teva Pharmaceuticals and Director Patent Attorney at Merck KGaA in Germany. Rachel began their career as a Patent Attorney at HGF Limited. Academic qualifications include a Doctor of Law (JD) from the University of Denver, a specialization in Intellectual Property Litigation from Nottingham Law School, and a PhD in Biochemistry and Molecular Biology from The University of Sheffield.